Provided By GlobeNewswire
Last update: Mar 19, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) (HKEX:13; Nasdaq/AIM:HCM) today reports its financial results for the year ended December 31, 2024 and provides updates on key clinical and commercial developments.
Read more at globenewswire.comNASDAQ:HCM (7/18/2025, 8:00:01 PM)
17.59
+0.07 (+0.4%)
Find more stocks in the Stock Screener